DataMeds AI financials
$3.67−3.67%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 | Q2 '23 Jun 30 | Q1 '23 Mar 31 | Q4 '22 Dec 31 | Q3 '22 Sep 30 | Q2 '22 Jun 30 | Q1 '22 Mar 31 | Q4 '21 Dec 31 | Q3 '21 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.7K | $0.00 | $128.7K | $392.3K | $366.5K | $493.3K | $2.3M | $2.1M | $3.3M | $3.2M | $2.4M | $2.6M |
| Gross profit | -$703.00 | $0.00 | -$114.0K | $39.6K | $67.1K | $73.2K | $1.5M | $1.4M | $1.2M | $1.3M | $1.2M | $1.3M |
| Gross margin | −3.8% | — | −88.6% | 10.1% | 18.3% | 14.8% | 67.2% | 66.8% | 35.7% | 41.2% | 51.9% | 50.2% |
| Operating income | -$1.5M | -$5.5M | -$2.3M | -$761.7K | -$599.8K | -$806.1K | -$187.0K | -$218.8K | -$1.1M | -$968.6K | -$782.3K | -$1.3M |
| Net income | -$1.8M | $21.2M | -$11.7M | -$3.5M | -$2.0M | -$678.0K | -$925.2K | -$503.0K | -$1.1M | -$960.1K | -$784.3K | -$1.3M |
| Net margin | −9807.5% | — | −9066.9% | −898.6% | −538.8% | −137.4% | −41.0% | −24.5% | −33.1% | −29.6% | −32.8% | −51.0% |
| Diluted EPS | $-1.30 | $16.77 | $-2.01 | $-1.49 | $-2.90 | $-1.01 | $-0.04 | $-0.91 | $-1.99 | $-0.12 | $-0.10 | $-0.16 |
| EBITDA | -$1.3M | -$5.2M | -$703.5K | -$349.4K | -$472.2K | -$555.1K | $47.9K | -$96.0K | -$912.0K | -$674.1K | -$134.6K | -$1.2M |
| Operating cash flow | $4.2M | -$10.2M | -$1.0M | -$603.1K | $328.6K | -$931.5K | $1.2M | -$578.5K | -$1.2M | -$999.2K | -$426.7K | -$738.1K |
| Free cash flow | $4.2M | -$10.2M | -$1.0M | -$742.0K | $189.7K | -$931.5K | $855.4K | -$634.3K | -$1.5M | -$999.2K | -$449.3K | -$738.1K |
| Diluted shares | 1.4M | 1.3M | 5.8M | 2.4M | 0.7M | 0.7M | 24.6M | 0.6M | 0.5M | 8.2M | 8.2M | 8.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $7.7M | $3.5M | $314.00 | $34.0K | $745.6K | $1.2M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $5.2M | $0.00 | $0.00 |
| Total assets | $14.8M | $16.7M | $12.5M | $21.7M | $3.7M | $4.0M |
| Total liabilities | $3.1M | $3.1M | $12.0M | $10.1M | $5.0M | $3.4M |
| Shareholders' equity | $11.8M | $13.6M | $542.4K | $11.6M | -$1.3M | $655.1K |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology